ARGXNasdaq

ARGENX SE

Biological Products, (No Diagnostic Substances) · P7 · CIK 1697862

ARGENX SE develops and commercializes antibody-based therapies for autoimmune diseases and cancer

$55.57B

Market cap

$927.77

Last close

+1.7%

+8.7%

359K

Volume

Price · last 40 sessions+14.4%

May 4L $776.26 · H $927.77Jun 30

203

Total filings

Jun 23, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance